Jillian S. Y. Lau

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

Borisov Se, Keertan Dheda, Martin Enwerem et al. · European Respiratory Journal · 2017 · 302 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial

Jesper Damsgaard Gunst, Jesper Falkesgaard Højen, Marie H. Pahus et al. · Nature Medicine · 2023 · 83 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Perspectives on Analytical Treatment Interruptions in People Living with HIV and Their Health Care Providers in the Landscape of HIV Cure-Focused Studies

Jillian S. Y. Lau, Miranda Z. Smith, Brent Allan et al. · AIDS Research and Human Retroviruses · 2019 · 50 citations · Full text

Public Health, Infectious Disease Control, Health Services Research +16

Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial

James McMahon, Jillian S. Y. Lau, Anna Coldham et al. · EClinicalMedicine · 2022 · 47 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +9

Memory CD4+ T cells that co-express PD1 and CTLA4 have reduced response to activating stimuli facilitating HIV latency

Thomas A. Rasmussen, Jennifer M. Zerbato, Ajantha Rhodes et al. · Cell Reports Medicine · 2022 · 38 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17